VAERS 2334815
MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U010746
- Staat
- IL
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 25.06.2022
- Impfdatum
- 17.06.2022
- Beginn
- 17.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Symptomtext
No additional AEs; PROQUAD and VARIVAX administered to 12 month old at same visit; This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of unknown gender. The patient's pertinent medical history, concomitant therapies, drug reactions and allergies were not reported. On 17-JUN-2022, at the same visit, the patient was administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD), 0.5 ml, lot #U010746, expiration date was not provided but upon internal validation was determined to be 03-OCT-2022; and varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 ml, lot #U010400, expiration date was not provided but upon internal validation was determined to be 01-APR-2023, both vaccines administered subcutaneously for prophylaxis (vaccine overdose). No additional adverse events (AEs) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -